Luc Debruyne D
President
Global Vaccines
Glaxosmithkline
Philippines
Biography
Luc was appointed President, Global Vaccines in 2013. Following the successful integration of the Novartis vaccines business acquired in early 2015, GSK Vaccines delivers today a broad portfolio of more than 30 paediatric, adolescent, adult/travellers and elderly vaccines to 90% of the world’s countries. Luc’s ambition for the business is to lead the industry in improving health globally, continuously delivering better vaccines and protecting more people while running our business sustainably. He is a member of the Corporate Executive Team.
Research Interest
hepatology